Association Between Mean Platelet Volume to Lymphocyte Ratio (MPVLR) and Diabetic Nephropathy Incidence in Type 2 Diabetes Mellitus
Main Article Content
Introduction. Diabetic nephropathy is a microvascular complication of uncontrolled diabetes mellitus (DM), with inflammation among its underlying pathogenesis. Inflammation causes fibrosis, increased vascular permeability, and podocytopathy, which lead to albuminuria. Mean Platelet Volume (MPV) measures thrombocyte size, which may mark increased metabolic and enzymatic activity of thrombocytes. An absolute decrease in lymphocytes occurs due to inflammation-induced decrease in apoptosis. MPVLR value can be used to assess low-grade inflammation in diabetic nephropathy in type 2 DM patients. This study aimed to determine the association between MPVLR values and diabetic nephropathy incidence in type 2 DM. Methods. This study was a cross-sectional study on type 2 DM patients at the Endocrinology outpatient clinic of Adam Malik Hospital aged ≥ 18 years. Sixty patients met the inclusion criteria. Complete blood count, creatinine, and albumin creatinine ratio (ACR) were performed to determine the incidence of diabetic nephropathy. Results. There was a significant difference in age between the diabetic nephropathy and non-nephropathy groups. There were significant differences in absolute lymphocyte count, Hb, HbA1c, and renal parameters such as estimated Glomerular Filtration Rate (eGFR) and creatinine between diabetic nephropathy and non-nephropathy groups. MPVLR showed a significant negative correlation with eGFR and Hb (r = -0.325, p = 0.011), showing that MPVLR increased in line with eGFR and Hb decrease. MPVLR was not significantly associated with diabetic nephropathy incidence based on semiquantitative ACR (p = 0.139). Conclusion. MPVLR was not associated with diabetic nephropathy in type 2 DM patients.
2. Kementerian Kesehatan Republik Indonesia. Survei Kesehatan Indonesia 2023. 2023.
3. Samsu N. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. Biomed Res Int. 2021;2021:1497449
4. Xu B, Zhang Y, Chen G, Feng J, Gan L. Association of mean platelet volume/lymphocyte ratio with inflammation in non-dialysis patients with chronic kidney disease stages 1-4: A retrospective study. Front Immunol. 2022;13:1041356
5. Aryani BR, Prabawa IMY, Saraswati MR. Peningkatan kadar Mean Platelet Volume-Lymphocyte Rasio (MPVLR) terhadap risiko nefropati diabetik pada pasien dengan diabetes melitus tipe II (DM-2) di RSUP Sanglah, Bali, Indonesia. Intisari Sains Medis. 2020;11(1):328-332.
6. Kocak MZ, Aktas G, Erkus E, Duman TT, Atak BM, Savli H. Mean Platelet Volume to Lymphocyte Ratio as a Novel Marker for Diabetic Nephropathy. J Coll Physicians Surg Pak. 2018;28(11):844-847.
7. Kurtul A, Acikgoz SK. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2017;120(4):534-541.
8. Chen SY, Lin YS, Cheng YF, Wang H, Niu XT, Zhang WL. Mean Platelet Volume-To-Lymphocyte Ratio Predicts Poor Functional Outcomes Among Ischemic Stroke Patients Treated With Intravenous Thrombolysis. Front Neurol. 2019;10:1274.
Selby NM, Taal MW. An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020;22(Suppl. 1):3–15.
9. Velasquez DC, Ventura WG, Velasquez AC, et al. Mean Platelet Volume Lymphocyte Ratio: Could It be a Game-Changer for Early Detection of Diabetic Nephropathy? - a Diagnostic Test Study. Blood. 2024;144(1):5399-5400.
10. Xu F, Qu S, Wang L, Qin Y. Mean platelet volume (MPV): new diagnostic indices for co-morbidity of tuberculosis and diabetes mellitus. BMC Infect Dis. 2021;21(1):461.
11. Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions. Mediators Inflamm. 2019;2019:9213074.
12. Sunardi, A., Dalimoenthe, N.Z., Rita, C. and Sugianli, A.K. The Correlation Between The Mean Platelet Volune Values With Thrombocyte Aggregation In Nephropathy Diabetic Patients. Indonesian Journal Of Clinical Pathology And Medical Laboratory. 2019;25(1):79-85.
13. Rustiasari UJ, Roelofs JJ. The Role of Platelets in Diabetic Kidney Disease. Int J Mol Sci. 2022;23(15):8270
14. Cassano V, Armentaro G, Iembo D, Miceli S, Fiorentino TV, et al. Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis: Platelets in cardiovascular risk. Cardiovasc Diabetol. 2024;23(1):89.
15. Winter L, Wong LA, Jerums G, Seah JM, Clarke M, Tan SM, et al. Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease. Front Endocrinol (Lausanne). 2018;9:225.
